Abstract
Around 70% of men presenting with prostate cancer will have organ-confined disease, with the majority presenting with low- or intermediate-risk prostate cancer. This article reviews the evidence supporting the current standard of care in radiation oncology for the evaluation and management of men with intermediate-risk prostate cancer. Dose escalation, hormonal therapy, combined modality therapy, and modern techniques for the delivery of radiation therapy are reviewed.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 113-124 |
| Number of pages | 12 |
| Journal | Therapeutic Advances in Urology |
| Volume | 4 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jun 2012 |
Keywords
- androgen deprivation
- brachytherapy
- dose escalation
- external beam
- intermediate risk
- outcomes
- prostate cancer
- radiation
- review
ASJC Scopus subject areas
- Urology
Fingerprint Dive into the research topics of 'Radiation treatment for patients with intermediate-risk prostate cancer'. Together they form a unique fingerprint.
Cite this
Greene, D. E., Mayadev, J. S., & Valicenti, R. K. (2012). Radiation treatment for patients with intermediate-risk prostate cancer. Therapeutic Advances in Urology, 4(3), 113-124. https://doi.org/10.1177/1756287212442977